Clinical Trial Update: A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and Teenagers [Phase 1]

View source ↗

Summary

A Phase 1 pediatric study evaluating how the long-acting insulin insulin icodec behaves in children and teenagers with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin Icodec (insulin icodec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED